<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01487746</url>
  </required_header>
  <id_info>
    <org_study_id>0125-11-MMC</org_study_id>
    <nct_id>NCT01487746</nct_id>
  </id_info>
  <brief_title>Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls</brief_title>
  <official_title>Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators expect to find higher levels of both classical and minor antiphospholipid
      (APL) antibodies among the stroke cases. Furthermore, the investigators expect to find not
      only classical APLA but also minor antibodies.

      The investigators believe that minor antibodies have a major role in the hypercoagulability
      state.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">September 2012</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">207</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>treatment</arm_group_label>
    <description>Stroke patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>healthy controls</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum samples of Stroke patients withdrawned within 36 hrs since stroke evoked. Healthy
      controls
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        on a bank of 207 stroke patients serum samples, and also on 40 healthy controls. The
        samples were collected during the acute phase of the ischemic event.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stroke diagnosis

          -  blood sampling within 36hrs from the event

          -  written agreement

        Exclusion Criteria:

          -  a stroke, MI or major operation prior to the current stroke

          -  hypercoagulable state known in this patient

          -  a severe chronic disease known at the time of the stroke

          -  an infection on arrival (based on anamnesis, physical exam and lab tests)

          -  thrombolytic treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yair Levy, Prof.</last_name>
    <phone>0533671735</phone>
    <email>levy.yair@clalit.org.il,</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Narin N Carmel, B.Sc</last_name>
    <phone>0547691482</phone>
    <email>carmeln@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Meir health center</name>
      <address>
        <city>Kfar-saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2011</study_first_submitted>
  <study_first_submitted_qc>December 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2011</study_first_posted>
  <last_update_submitted>December 6, 2011</last_update_submitted>
  <last_update_submitted_qc>December 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>APLA</keyword>
  <keyword>APS</keyword>
  <keyword>Stroke</keyword>
  <keyword>minor anti body</keyword>
  <keyword>major anti body</keyword>
  <keyword>APLA antibodies in Serum</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
    <mesh_term>Immunoglobulins</mesh_term>
    <mesh_term>Antibodies, Antiphospholipid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

